Echo Therapeutics, Inc. - FORM 10-Q - EX-10.1 - FIRST AMENDMENT TO THE CONSULTING AGREEMENT ENTERED INTO AS OF OCTOBER 3, 2013 BY AND BETWEEN THE REGISTRANT AND ROBERT F. DOMAN. - November 7, 2013

Attached files

file filename
EX-31.1 - CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002. - Echo Therapeutics, Inc.ex31-1.htm
EXCEL - IDEA: XBRL DOCUMENT - Echo Therapeutics, Inc.Financial_Report.xls
EX-32.1 - CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002. - Echo Therapeutics, Inc.ex32-1.htm
EX-31.2 - CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002. - Echo Therapeutics, Inc.ex31-2.htm
EX-32.2 - CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002. - Echo Therapeutics, Inc.ex32-2.htm
10-Q - Echo Therapeutics, Inc.ecte10qsept302013.htm
Exhibit 10.1

FIRST AMENDMENT
TO CONSULTING AGREEMENT
   
    This FIRST AMENDMENT TO CONSULTING AGREEMENT is entered into as of October 3, 2013 (the “Amendment”) by and between Echo Therapeutics, Inc., a Delaware corporation (the “Company”), and Robert F. Doman, an individual (“Consultant”).
 
RECITALS
 
    WHEREAS, reference is hereby made to the Consulting Agreement entered into as of August 26, 2013 (as amended, restated, supplemented or otherwise modified, the “Agreement”) by and between Consultant and the Company; and
 
    WHEREAS, Consultant and the Company have mutually agreed that the financial terms of the Agreement be amended as set forth herein.
 
    NOW, THEREFORE, the parties hereto agree as follows:
 
    1.  Defined Terms.  Unless otherwise defined herein, terms used herein are used as defined in the Agreement, as amended hereby.
 
    2.  Amendment of the Agreement.  Section 3(a) of the Agreement is hereby amended by replacing the phrase “$2,500 per day” with “$8,000 per calendar week”.  Except as expressly modified herein, all other provisions of the Agreement shall remain unchanged and in full force and effect.
 
    3.  Effective Date.  This Amendment shall be effective as of August 26, 2013.
 
    4.  Governing Law.  This Amendment shall be governed by and construed in accordance with the laws of the Commonwealth of Pennsylvania.
 
    IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed as of the date first above written.
 
 
ECHO THERAPEUTICS, INC.

 
By: /s/ William Grieco
 
 
William Grieco
Chairman, Nominating and Corporate Governance Committee of the Board of Directors
 
Dated:  October 3, 2013

 
 
ROBERT F. DOMAN
 
By: /s/ Robert F. Doman
 
Dated: October 3, 2013

Echo Therapeutics, Inc. Reports